益方生物业绩快报：2025年度归母净利润亏损3.17亿元

Group 1 - The company reported a revenue of 37.3253 million yuan for the fiscal year 2025, representing a year-on-year decline of 77.89% [1] - The net profit attributable to shareholders was a loss of 317 million yuan, compared to a loss of 240 million yuan in the same period last year [1] - The basic earnings per share were -0.55 yuan [1]